CHEMBIO DIAGNOSTICS, INC. Deferred Tax Assets, Valuation Allowance
CHEMBIO DIAGNOSTICS, INC. had Deferred Tax Assets, Valuation Allowance of $27.92 million as of 2022-12-31, per its 10-K filed 2023-03-29.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2023-03-29
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $27.92M.
- 2021-12-31: Deferred Tax Assets, Valuation Allowance $24.03M.
- 2020-12-31: Deferred Tax Assets, Valuation Allowance $17.37M.
- 2019-12-31: Deferred Tax Assets, Valuation Allowance $12.34M.
| Period end | Deferred Tax Assets, Valuation Allowance |
|---|---|
| 2022-12-31 | $27.92M 10-K · filed 2023-03-29 |
| 2021-12-31 | $24.03M 10-K · filed 2023-03-29 |
| 2020-12-31 | $17.37M 10-K · filed 2022-03-03 |
| 2019-12-31 | $12.34M 10-K · filed 2021-03-11 |
| 2018-12-31 | $9.48M 10-K · filed 2020-03-13 |